Nova Eye Medical Limited
ELXMF
$0.00
-$0.10-98.10%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 19.82% | 9.47% | -2.26% | 24.42% | 40.83% |
| Total Depreciation and Amortization | -29.24% | -27.97% | -26.26% | 9.50% | 69.92% |
| Total Amortization of Deferred Charges | 121.98% | 127.46% | 463.64% | -128.45% | -131.67% |
| Total Other Non-Cash Items | -18.05% | 240.27% | 1,432.17% | -66.45% | -89.51% |
| Change in Net Operating Assets | 73.93% | 73.93% | 73.93% | -39.82% | -1,104.03% |
| Cash from Operations | 34.56% | 28.83% | 22.45% | 6.39% | -13.02% |
| Capital Expenditure | -202.34% | -94.22% | -38.87% | 31.24% | 70.40% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -36.18% | 20.00% | 42.20% | 50.14% | 58.01% |
| Cash from Investing | -153.50% | -56.23% | -10.31% | 36.55% | 67.63% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -21.08% | -19.73% | -18.34% | 5.59% | 23.32% |
| Issuance of Common Stock | -16.97% | -16.97% | -16.97% | -8.73% | -0.54% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -23.06% | -22.88% | -22.83% | -11.67% | -0.99% |
| Foreign Exchange rate Adjustments | -25.52% | -99.83% | -6,021.43% | -50.73% | 69.23% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 173.93% | 46.23% | 1.37% | -39.70% | -362.77% |